Research programme: antibody recruiting molecules - Allied Bristol Life Sciences/Yale UniversityAlternative Names: ARMs - Allied Bristol Life Sciences/Yale University
Latest Information Update: 06 Oct 2015
At a glance
- Originator Yale University
- Developer Allied-Bristol Life Sciences
- Class Small molecules
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Prostate cancer